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Abstract: In this review, reports were retrieved in which vitamin D status, as assessed by serum
25-hydroxyvitamin D [25(OH)D] levels, was measured in South African population groups with
varied skin colours and ethnicities. Healthy children and adults were generally vitamin D-sufficient
[25(OH)D level >50 nmol/L] but the majority of those aged above 65 years were deficient. A major
role for exposure to solar ultraviolet radiation (UVR) in determining 25(OH)D levels was apparent,
with the dietary contribution being minor. Limited data exist regarding the impact of recent
changes in lifestyles on vitamin D status, such as urbanisation. With regard to disease susceptibility,
11 of 22 relevant publications indicated association between low 25(OH)D levels and disease, with
deficiency most notably found in individuals with tuberculosis and HIV-1. Information on the
relationship between vitamin D receptor variants and ethnicity, disease or treatment response in the
South African population groups demonstrated complex interactions between genetics, epigenetics
and the environment. Whether vitamin D plays an important role in protection against the range
of diseases that currently constitute a large burden on the health services in South Africa requires
further investigation. Only then can accurate advice be given about personal sun exposure or dietary
vitamin D supplementation.
Keywords: 25(OH)D levels; HIV-1; tuberculosis; vitamin D receptor; sun exposure
1. Introduction
Vitamin D deficiency is a risk factor for rickets in children and osteomalacia in adults [1]. Recently,
with the recognition that the active form of vitamin D is immunoregulatory, vitamin D deficiency has
been proposed to increase the likelihood of a wide range of common human disorders [2,3], including
various autoimmune, infectious and cardiovascular diseases, and internal cancers, several of which
occur in South Africa at rates exceeding those reported globally. While there has been considerable
research on vitamin D in developed countries [4,5], this has not been matched in developing countries
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where the impact of vitamin D deficiency on health may be greater in terms of disease burden.
Therefore in this review, we gather together all the published information regarding vitamin D in the
context of South Africa. Our main aims were to establish whether there was widespread vitamin D
deficiency in any population group and to investigate whether there was robust evidence to associate
low vitamin D status with any of the diseases, prevalent currently in South Africa.
In most people, exposure of the skin to solar ultraviolet radiation (UVR) in the UV-B
range (290–315 nm) is the main route for synthesis of vitamin D. Absorption of UVR converts
7-dehydrocholesterol in the lower epidermis to previtamin D3 which then undergoes thermal
isomerisation to vitamin D3. This is followed by hydroxylation, first to 25-hydroxyvitamin D [25(OH)D]
mainly in the liver, and then to 1,25-dihydroxyvitamin D [1,25(OH)2D] mainly in the kidney [6].
Both 25(OH)D and 1,25(OH)2D are transported in the blood linked to the vitamin D binding protein
(DBP, also known as group-specific component [Gc]). 1,25(OH)2D binds to the vitamin D receptor
(VDR) in the membrane and/or the nucleus of a wide variety of cell types. In addition many
non-renal cells can convert 25(OH)D to 1,25(OH)2D, thus providing a source of 1,25(OH)2D for
tissue-specific intracellular action [7]. Binding of 1,25(OH)2D facilitates the VDR to form a heterodimer
with the retinoid X receptor (RXR), leading to the activation of the VDR-RXR transcription complex.
This regulates the expression of more than 900 genes, thus affecting a myriad of signalling cascades in
the body [8].
Vitamin D is present in some foods, as vitamin D3 (cholecalciferol) from animal sources and
as vitamins D3 and D2 (ergocalciferol) from plant sources. Both forms are absorbed from the small
intestine together with dietary fat, and incorporated into chylomicrons which are rapidly transported
via the lymphatics and then via the venous blood, bound to the DBP, to the liver. A limited number of
staple foodstuffs, such as cereals and dairy products, are fortified with vitamin D in many developed
countries. Finally dietary supplements are widely available, containing either vitamin D2 or D3 in a
wide range of dosages.
Vitamin D status is commonly measured as the total plasma or serum concentration of the
sum of 25(OH)D2 and 25(OH)D3, both bound to DBP and albumin, as well as unbound (“free”) [9].
The cut-off points for sufficiency, insufficiency and deficiency are not agreed at present. In their 2011
report, the US Institute of Medicine focussed on bone health and defined <30 nmol/L 25(OH)D
as deficient, 30–50 nmol/L as insufficient and >50 nmol/L as sufficient [10]. Others such as
Bischoff-Ferrari et al. [11] and the US Endocrine Society [12] have defined <50 nmol/L as deficient,
50–75 nmol/L as insufficient and >75 nmol/L as sufficient, based on the skeletal and non-skeletal
health benefits of vitamin D. In the following section, a 25(OH)D concentration of >50 nmol/L in
people without disease was taken as being sufficient as the levels relating to bone are not generally
disputed, while those relating to the other possible in vivo benefits of vitamin D remain uncertain.
It should be noted that the accuracy and reproducibility of the assays that measure 25(OH)D
are variable [13,14]. At present quality assurance-validated liquid chromatography-tandem mass
spectroscopy (LC-MS/MS) is considered by many as the “gold standard” method [13], but the
lower-cost competitive immunoassay, which varies by supplier, is often used and may give different
results from LC-MS/MS, thus confounding comparison between studies.
South Africa consists of nine provinces, spanning latitudes 22.34◦ S to 34.28◦ S (Figure 1).
The country has a narrow coastal plain at sea level, rising to mountains over 3000 m in height,
with a large plateau, the Highveld, at an altitude of 1200 m. High atmospheric pressure over this
Northern plateau frequently results in cloudless skies and, in combination with the altitude, leads to
high levels of ambient solar UVR. As an illustration of the climatic variation between the Northern
and Southern regions of South Africa, the temperature, UV Index, and number of hours of sunshine
per day in the winter and summer are shown in Table 1 for Cape Town representing the South, and
Pretoria representing the North Highveld. These conditions have the potential to result in variable
seasonal personal exposure to solar UVR, with implications for the production of vitamin D [15].
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Table 1. Weather conditions in Cape Town and Pretoria; data from [16–18].
Parameter
Cape Town
Latitude 35◦ S, Altitude 0–300 m
Pretoria
Latitude 26◦ S, Altitude 1339 m
Summer Winter Summer Winter
Average hours of sunshine per day 11 5 10 8
Ultraviolet index 9–10 2–3 11+ 4–6
Average temperature in ◦C,
minimum/maximum 16/26 7/18 18/28 5/20
Figure 1. The number of publications investigating the association between vitamin D status and
disease in the Provinces of South Africa. Green indicates a significant association, and white indicates
no significant association. The size of the Venn diagrams is proportional to the number of studies.
Map adapted from Global Security [19] and the Venn diagrams were plotted using GraphPad PRISM 6.
The population of South Africa is multi-ethnic and complex, with phototypes ranging from deeply
pigmented to fair [20]. The South African government collects demographic data on four ethnic groups:
in 2014, the National Census estimated the population as 54 million of whom 80.2% were Black African,
8.8% Coloured (mixed ancestry between White and Black or Black and Asian, with skin colour ranging
from pale to dark brown), 2.5% Asian/Indian (frequently termed Indian in South Africa) and 8.4%
White [21]. Approximately 10% of the population is infected with HIV-1 currently, one of the highest
prevalences in the world, and the incidence of tuberculosis (TB) is the third highest in the world.
Epidemiological transition in South Africa, occurring particularly since the end of apartheid in 1994,
means that many social factors relating to personal sun exposure and hence to vitamin D status may
have changed in recent years.
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In this article, published studies measuring the vitamin D status of various healthy South African
populations are reviewed first. These provide information to indicate whether any population group,
defined by age or ethnicity or location of residence, is vitamin D-deficient. Such a status may lead
to deleterious consequences for health. It is important to try to construct simple messages for the
public regarding “safe” sun exposure that ensures sufficient vitamin D status while not increasing the
risk of the adverse effects of intense UVR. This topic is considered in the context of the large range
of South African phototypes. Next, as urbanisation may affect vitamin D status, either positively
through improvements in lifestyle and diet, or negatively through less time spent outdoors, this aspect
is reviewed. Information regarding disease and vitamin D deficiency is then evaluated in the context
of South Africa. This country has a high burden of diseases such as TB and HIV, so the possibility of a
low vitamin D status increasing the risk of the disorder or its severity is of particular interest. Finally
recent information is reviewed regarding the effect of the VDR polymorphisms, found in the diverse
populations of South Africa, on susceptibility to disease, particularly TB.
2. Vitamin D Status in South Africa
Several recent reviews have provided information on global vitamin D status [4,5,22], but all of
these lack data for most African countries, including South Africa. In this section, all the publications
were retrieved in which 25(OH)Dwas assessed with the aim of determining whether any South African
population group, defined by age or skin colour or place of residence, was vitamin D-deficient.
A systematic search was conducted using PubMed, covering the period 1978 to mid-2015, with the
terms “vitamin D” AND “South Africa” AND “(status or prevalence or deficiency)”. By title, 220 papers
were found; this number was reduced to 85 after reading the abstracts, and further reduced to 19
after considering the full reports: these are listed in Table 2 with a summary of each set of findings.
Publications involving case reports, clinical management and reviewswere excluded. Reports assessing
25(OH)D levels in people with various diseases and the control groups are described in a later section.
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The results were compared for variation in the methods assessing 25(OH)D level, sample size,
the age and population groups of the participants, the latitude of the study location and the time of
year of sampling. Several different assays were used to determine the concentration of 25(OH)D in
plasma or serum, ranging from competitive protein binding to LC-MS/MS more recently. Results
from these different methods may not be comparable. Sample sizes tended to be smaller in older
reports compared with more recent studies. The findings of each investigation varied, and included
people at only one location. The sampling frames are indicated in Table 2, and show that they were
limited to particular groups and did not reflect the demographics of the population as a whole. Thus
none of the results in the 19 publications could be considered as providing an accurate reflection of
the entire South African population. The participants varied in age from infants to the elderly, and
were stated as belonging to the Black African, Coloured, Asian/Indian or White population groups in
all but three cases [31,39,40]. Residence ranged from latitude 24–35◦ S, within both rural and urban
communities, but it should be noted that only five of the studies were based in the South of the country.
Samples were collected throughout the year in seven investigations and, of these, 25(OH)D levels
were assessed in each of the four seasons in five [25,28,31,36,39], with a mean value for the year given
in the other two [33,37]. The season of sampling was stated as being solely in the winter in three
instances [23,39,41] and at the end of the summer in another one [26]. There was one longitudinal
study in which 25(OH)D levels were assessed in the summer and the following winter in the same
participants [38]. It is particularly important to obtain this information because 25(OH)D levels may
decrease in the winter months, especially in the southern part of South Africa, as the quantity of UV-B
in solar UVR reduces. In the remaining eight investigations, the time of year when the samples were
collected was not specified.
Despite these difficulties, an overview of the studies in Table 2 indicates that 25(OH)D levels
were generally sufficient in most healthy children (birth to 18 years old) with black, coloured
and white skin (mean value approximately 84 nmol/L) [23,24,26,28], but were about 24% lower
in Black African children compared with age-matched White children [28]. It is of note that all
of these studies were located in the Northern provinces of South Africa and that four of them
were conduced prior to 1986 [27–30] so their relevance to the current vitamin D status of children
throughout South Africa who are undergoing rapid urbanisation, and particularly to those living in
the Southern provinces is uncertain. In addition the results using assays for 25(OH)D at that time
may not correlate with the assays used currently. The levels of 25(OH)D were sufficient in most
healthy Black African (mean approximately 67 nmol/L) and White (mean approximately 65 nmol/L)
adults (aged 18–54 years) [29,30,32,37], but insufficient in many Asian/Indians (mean approximately
42 nmol/L) [33,35,36], hypothesised to be due to the cultural preference to clothe most of the body.
Three studies undertaken prior to 1997 in elderly people (>65 years) showed a high prevalence of
vitamin D deficiency (mean approximately 38 nmol/L) [39–41]. However in the only study since then
which included data on the elderly, a mean level of 65 nmol/L in healthy Black African women over
the age of 70 years was found [32]. Males tended to have higher 25(OH)D levels than age-matched
females in two recent reports [28,33], and the levels decreased with age, both during adolescence [27],
and in adults [32]. Levels were higher in the summer/autumn (peak in autumn) compared with the
winter/spring [33,36,39], and, in the only longitudinal study, decreased from sufficiency in the summer
to less than 50 nmol/L in the winter in both the Black African and Coloured groups in Cape Town [38].
They also tended to decrease with increasing distance from the Equator [37].
3. Sun Exposure and Photoprotection in Relation to Vitamin D Production in South Africa
The Cancer Association of South Africa produced a Vitamin D Sun Exposure Statement in 2014 [42].
While this document details dietary sources of vitamin D and mentions links between vitamin D
deficiency and certain diseases, it does not provide guidance on how much time to spend in the sun to
produce sufficient vitamin D in South Africa, and does not distinguish between people with fair and
darkly pigmented skin. In fact, there is no scientifically validated and agreed safe threshold level of
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sun exposure that allows for optimal vitamin D synthesis without increasing the risk of harm. Chronic
unprotected personal exposure to solar UVR and excess exposure leading to sunburn are associated
with several adverse health effects, including skin cancer and cataract [43]. Personal photoprotection,
such as broad-brimmed hats, clothing, shade and sunscreen, is recommended by the World Health
Organization during peak solar UVR hours around midday, and at any time when the UV Index
is ≥3 [44]. A combination of these methods reduces over-exposure effectively. Studies carried out
predominantly in people with fair skin living in Australia, USA and Europe indicate that sunscreen
usage does not affect 25(OH)D levels significantly [45], although a small decrease occurs if they are
applied at frequent intervals and at the correct thickness, neither of which are common practice [46].
A systematic search using PubMed with the terms “sun exposure/sun protection” AND
“South Africa” AND “vitamin D” identified 18 articles by title. After excluding case and clinical
management reports and reviews, and consideration of the full papers, the number was reduced to
nine. One study in Durban (latitude 30◦ S) showed that children, aged 6 years, received about 5%
of the total daily ambient solar UVR [47], similar to that received by children in Australia [48] and
England [49]. A nationwide study among primary schoolchildren in South Africa suggested that
about half of the children ever wore a hat and/or used sunscreen [50]. Even amongst those at high
risk of sunburn and skin cancer, as is the case for individuals with oculocutaneous albinism, personal
photoprotection is frequently minimal [51,52].
As already indicated, several reports based in South Africa demonstrate a major role of solar UVR
in determining vitamin D status [28,33,36,38,39]. Daily sunshine hours by season were noted in a study
of the vitamin D status of children in Johannesburg but were not analysed in relation to 25(OH)D
level [28]. One in vitro study showed that exposure of vials containing 7-dehydrocholesterol to sunlight
for one hour at different times on one day in each month of the year resulted in the same quantity
of vitamin D being produced in Johannesburg throughout the year, but the quantity was reduced to
about one-third during the winter months in Cape Town compared with the summer months at this
location [15]. It was suggested that the decrease in the vitamin D status of people living in Johannesburg
in the winter months may be due to the drop in temperature, and consequently increased clothing
and decreased time spent outdoors, rather than to the reduction in ambient solar UVR. Two studies,
one in Johannesburg and the other in Cape Town, have quantified the participants’ recollection of
daily sun exposure during the past week using a questionnaire, and then related this to their 25(OH)D
level [36,38]. Daily sun exposure scores, based on duration of time spent outdoors and amount of skin
exposed, were positive predictors of 25(OH)D concentration among Black Africans in Johannesburg,
and season and sun exposure explained 17% of the variance in 25(OH)D concentration [36]. Daily sun
exposure scores did not predict 25(OH)D concentration among Asian/Indian participants who were
mainly veiled females. In the Cape Town populations, personal sun exposure was the strongest
determinant of 25(OH)D level, driven by the area of skin exposed and duration of exposure [38]. Black
African participants spent about 4 h longer each week in the sun in both winter and summer than
Coloured participants, and they exposed larger areas of their bodies in the summer, while both groups
reduced their body exposure to similar levels in the winter [38].
4. Effect of Urbanisation and Diet on Vitamin D Status in South Africa
African countries are amongst the fastest urbanising in the world [53]. In South Africa, official
government projections estimate that, between 2011 and 2016, the provinces of Gauteng and Western
Cape will experience an inflow of 1.5 million migrants, many from the Eastern Cape and Limpopo [21].
Generally these people feel driven to move because of population growth and associated economic and
social pressures. The situation has worsened over the past 25 years due to large-scale intensive farming
at the cost of traditional small-scale subsistence-based production. With urbanisation, changes in
lifestyle occur which may lead to reduced personal solar UVR exposure, with the potential to decrease
vitamin D status. For example, office work is less conducive to time spent in the sun, and urban
environments, such as tall buildings and narrow streets, may limit direct sun exposure. As urbanization
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frequently leads to changes in the diet which may, in turn, affect vitamin D status, these two aspects
are considered in this section.
A systematic search was conducted using PubMed for papers published in English, with no limit
on years and with the terms “vitamin D” AND “South Africa” AND “rural” OR “urbanisation” OR
“semi-rural”. By title 165 articles were found. After excluding duplicates and studies that were not
about South Africa or vitamin D, 50 papers remained which were reduced to 15 after reading the
abstracts. These provided relevant information on the diet of South African populations, defined as
living in urban, semi-rural or rural settings. Papers were excluded if they focused on vitamin D in
relation to a disease outcome, if they did not present original data, or if they did not specifically present
results for vitamin D intakes or serum 25(OH)D levels.
Only two investigations compared 25(OH)D levels in rural and urban populations in South Africa.
In a study of Black African women in the North West Province in 2011, Kruger et al. [32] found that
serum 25(OH)D levels were lower in urban women aged between 50 and 70 years (urban: 63 nmol/L;
rural: 71 and 75 nmol/L, depending on age decade), but similar between urban- and rural-living
women <50 years and >70 years. More than 30 years earlier, Pettifor et al. [24] analysed 25(OH)D
levels in 60 black children living in rural, small urban and large urban communities near Johannesburg.
The mean values were 72.3, 77.3 and 82.8 nmol/L respectively, thus indicating a small increase in
vitamin D status with urbanisation. However it should be noted that the sample size was small, the
assay may have given different results from the assays currently employed, the standard deviations
were large and, as the children were of primary school age, they might spend considerable time
outdoors, even in an urban environment.
Dietary intake of vitamin D is low in African countries in both urban and rural environments, and
the contribution of 25(OH)D2 to the overall 25(OH)D status is minor [36,37]. In South Africa, many
margarines are fortified with vitamin D (one brand contains 9200 IU/Kg) but other foods are not,
and few foods available to the majority of the population contain significant amounts of vitamin D.
In rural KwaZulu-Natal, the mean dietary vitamin D intake was considerably less than the dietary
recommended intake of 15 μg/day (600 IU/day) [54,55]. Although the diets of urban Black African
women in the north-west Provinces of South Africa were healthier than those of rural women, all of
the participants had low vitamin D intakes (means from 1.79 to 3.28 μg/day), and urban women were
more likely to be obese [32]. Elderly Black African people in a peri-urban environment near Cape Town
also had low average vitamin D intake [56], as did healthy Black African and Coloured 18–24 year olds
in the same region [38]. Low vitamin D intake was consistently found in both Black African (median
2.96 μg/day) and Asian-Indian (median 1.17 μg/day) adults in the Johannesburg area, with a marked
difference in the prevalence of vitamin D supplementation use: 1.9% of Black African adults and 14.9%
of Asian-Indian adults [36].
Low intake of vitamin D and calcium have been hypothesised as a cause of the high prevalence of
stunting in children aged 2–5 years (36.9% had stunted growth) in a semi-urban impoverished setting
in the Hantam district of the Northern Cape Province [57]. Similar low vitamin D intake was reported
amongst 5-year old children living in the urban Johannesburg/Soweto area [58].
With such limited information, it is not possible currently to determine whether urbanisation
with or without associated changes in the diet leads to an overall increase or decrease in the vitamin D
status of an individual in South Africa. In addition the definition of what constitutes urban and rural
may differ between the studies described above.
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5. Association of Vitamin D Status with Diseases in South Africa
One of the major research interests in vitamin D at the present time lies in investigating the
possible association of low 25(OH)D levels with various diseases. This aspect is considered in detail
below in the context of South Africa, and is of particular relevance to the infectious diseases commonly
found in this country. A systematic search was conducted using PubMed, covering 1973 to mid-2015,
with the terms “vitamin D” AND “South Africa” AND “(disease or health or infection)”. By title,
117 papers were found; this was reduced to 25 after reading the abstracts, and to 22 after reading
the full reports. Papers were excluded for six reasons: a review or commentary; non-South African
population; no in vivo data; no disease association; not human; 25(OH)D not measured. Details of
each study are shown in Table 3 and their geographic location in Figure 1. It is notable that 15 of
these papers have been published since 2011, reflecting the recent rise of interest in vitamin D and
health outcomes. The most common diseases studied were bone pathologies and infectious disease
(ID), each representing 9 of the 22 reports, with one investigating bone growth and vitamin D status
in HIV-1-infected women [62]. The threshold for vitamin D sufficiency and deficiency as defined in
each of these articles was used as it was not possible to re-calculate statistical significance using one
standard value from the data presented.
Of the 22 studies, 11 found a significant inverse association between 25(OH)D level and disease
presentation, severity or pathogenesis (Table 3). It should be noted that, in four of the other 11 studies
that did not find association, the comparison was between HIV-1-associated disease states, such as
HIV-1 vs. HIV-1-cryptococcal meningitis [63], rather than between disease vs. healthy control, and
vitamin D deficiency was present in 42%–74% of the HIV-1 infected persons. The significant inverse
correlation between disease presentation and 25(OH)D levels was more prevalent in studies conducted
in southern and western provinces where, due to the higher latitude in the south and lower altitude in
the south and west compared with the central/northern Highveld, there is less solar UV-B radiation in
the winter months, and thus the likelihood of seasonal deficiency is greater (Figure 1). The association
between disease and seasonal sunlight hours was highlighted in three studies, two indicating lower
incidences of TB and TB meningitis following the summer increase in solar UVB radiation [64,65].
The third showed a decrease in HIV-1 replication in peripheral blood mononuclear cells (PBMCs),
collected in the summer and infected ex vivo in autologous serum, compared with HIV-1 replication in
PBMCs from the same individual collected in the winter [38].
Aside from the accepted link between vitamin D deficiency and bone mineralisation, the recent
focus of vitaminD research in South Africa onHIV-1 and TB reflects the burden of these chronic diseases
in this country. Seasonal vitamin D deficiency was significantly associated with disease or HIV-1
replication in three studies from the Western Cape [38,64,65], with vitamin D deficiency more severe in
patients co-infected with HIV-1 and Mycobacterium tuberculosis [64]. Three multinational cohort studies
which included participants from Gauteng and/or KwaZulu-Natal also found vitamin D deficiency
in approximately 40%–50% of HIV-1-infected patients, but there was no control comparison group
so that disease association could not be assessed [67–69]. Participants from the PEARLS (Prospective
Evaluation of Antiretrovirals in Resource Limited Settings) trial were used in two of these studies.
At 24 weeks after initiation of antiretroviral therapy (ART), patients receiving efavirenz-containing
regimes had significantly decreased serum 25(OH)D concentration, with the greatest decrease occurring
in those with higher baseline 25(OH)D levels. Notably ART did not improve micronutrient deficiency
in HIV-1-infected persons [67,68].
Vitamin D deficiency may be the result of both HIV-1 infection and loss of HIV-1 killing
mechanisms with a further decrease in CD4+ T cells [72]. The HIV-1 viral envelope protein gp120
induces CYP27B1 expression [73], the enzyme which metabolises 25(OH)D, indicating that infection
may contribute to decreased circulating 25(OH)D and vitamin D deficiency. There is also a variety of
immune pathways regulated by vitamin D, leading to inhibition of HIV replication [74–76]. As well as
this antimicrobial activity, vitamin D can also reduce HIV replication by affecting the production of
factors, such as NF-kB, which are required for transcription of the long terminal repeat of HIV-1 [77–79].
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The nine studies on bone health included six investigating rickets, stunting or metabolic bone
disease in children and adolescents in the Northern and Eastern Provinces [22,25,57,59,61]. Three found
significant association between low vitamin D intake and disease, or clinical improvement following
three months of vitamin D supplementation (5000 IU/day) [25,57,59]. In the three that did not
detect association, there was a high prevalence of vitamin D deficiency in the children investigated,
particularly in those hospitalised. It is possible that the duration of deficiency could be an important
determinant of disease development [25].
Bone mineral density (BMD) and vitamin D status were also examined in two studies of older
adults in Gauteng and North-West Province [32,35]. No association between 25(OH)D levels and BMD
was demonstrated in either report. However the concentration of parathyroid hormone (PTH), which
upregulates 1,25(OH)2D production from 25(OH)D, thus increasing intestinal calcium absorption,
was inversely correlated with BMD in Asian-Indian participants in Gauteng [35]. In Black African
women in the North-West Province, 25(OH)D levels were inversely correlated with the concentrations
of PTH and C-terminal telopeptide of Type 1 colleagen (CTX, a measure of bone resorption) in rural
participants; urban participants had lower CTX levels which correlated with dietary calcium and PTH,
the PTH in turn correlating with 25(OH)D. This suggests that urban women might be at risk of high
bone resorption in response to calcium insufficiency and low vitamin D status [32].
Three of the 22 reports considered association between cardiovascular disease or
obesity/metabolic syndrome and 25(OH)D levels. The incidences of cerebrovascular disease, heart
disease, and type 2 diabetes mellitus (T2DM), representing the third, fourth and fifth highest cause of
mortality in South Africa, after TB and influenza/pneumonia, are all increasing currently, indicating
their importance to the health of the country [80]. Only one study investigated vitamin D status and
indicators of cardiovascular disease, finding that women with low 25(OH)D levels had significantly
higher systolic blood pressure [34]. Using the same cohort of adults in greater Johannesburg, elevated
PTH, not low 25(OH)D, predicted metabolic syndrome, although 25(OH)D inversely correlated
with PTH [33,34]. It should be noted that it is not possible to separate cause and effect from such
cross-sectional studies, and there many be confounding by factors such as physical activity which
may relate to both time in the sun and disease risk. Any link between vitamin D status and T2DM in
South African populations has not been investigated thus far. In addition, although cancer causes 8.3%
of all deaths in South Africa, no association with vitamin D status has been sought. This is despite
some evidence supporting a role for vitamin D in the regulation of cell differentiation, angiogenesis
and matrix remodelling, all key components of metastasis [81].
Other non-communicable outcomes investigated included the management of zinc deficiency
in Alzheimer’s [59], and the association between alcohol use disorders and vitamin D status in
adolescents [60]. The former study found that adjunct vitamin D supplementation together with
zinc and vitamin A was more effective at increasing zinc levels, than zinc alone [70], suggesting an
interaction between micronutrients. Chronic alcohol use in Western Cape adolescent 12–16 year olds
was significantly associated with lower serum 25(OH)D and calcium levels and all the participants
had inadequate dietary intakes of vitamin D [71].
6. Vitamin D Receptor Gene (VDR) Polymorphisms and Ethnicity in South Africa
The VDR, the gene encoding the vitamin D receptor protein (VDR), spans more than 100 kb on
chromosome 12. Besides eight protein-coding exons (2–9), almost half of the VDR sequence serves
regulation, including six, largely noncoding, exons (1a–1f). Four promoters and four enhancers regulate
transcription from the VDR and alternative splicing delivers at least nine splice variants encoding
different proteins. Having nine bona fide CpG islands (CGIs) and three miRNA recognition elements in
its 3’ UTR, VDR is regulated in a complex fashion through genetics, epigenetics and environment [82].
VDR polymorphisms most commonly studied include FokI, BsmI, ApaI and TaqI, named after restriction
enzyme cleaving sites. Their alleles are referred to as either letters or nucleotides, such as FokI
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(rs2228570, previously rs10735810, C/T or F/f [lower case indicating restriction site presence]), BsmI
(rs1544410, A/G or A/a), and TaqI (rs731236, T/C or T/t).
Different ethnicities in South Africa have evolved at different geographical locations under diverse
conditions. Selection factors established unique combinations of genetic and epigenetic variants for
optimal function of genes and pathways, including that of vitamin D [83,84]. Recent lifestyles changes
which lead to less exposure to solar UVR, together with DBP and VDR genetic variants with low
affinity for 25(OH)D, the frequency of which differs between population groups, may contribute to
disease susceptibility.
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In the following section, information on theVDR variants found in the populations of South Africa
was collated, with the aim of determining the function of such polymorphisms in relation to the risk
of disease or an association with ethnicity. Reports on the association of VDR variants with ethnicity,
disease or treatment response, VDR DNA methylation and VDR function in South Africans were
identified using the PubMed search terms: VDR polymorphism AND South Africa AND (disease OR
health OR infection OR infectious OR seasonal OR ethnicity OR pigmentation) OR (seasonal variation
AND infectious disease AND polymorphism AND pigmentation AND nutrition). Of the eleven
papers identified, seven were relevant experimental reports investigating VDR polymorphisms in
South African populations (Table 4). Five related to disease [38,86,87,89,90], and two to ethnicity
alone [85,88]. The first study on VDR single nucleotide polymorphisms (SNPs) in South African
Whites, Blacks and Asian-Indians showed a significantly higher frequency of TaqI “TT” and ApaI
“AA” genotypes in Blacks compared to Whites and Asian-Indians [85]. A case-control study in the
Black Venda people living in Limpopo Province found no independent VDR SNP association with
pulmonary TB, but protection by FokI-BsmI-ApaI-TaqI haplotype, “F-b-A-T”, proposed to encode a VDR
variant with more effective transactivation of target genes [86]. In a South African Coloured population
in the Western Cape, VDR polymorphisms were associated with time to conversion of sputum to
smear negativity during chemotherapy of patients with pulmonary TB, but there was no association
with susceptibility to TB [87]. A second study of the Venda revealed a complex association of TaqI
with the methylation status of the 3’ region CGI 1060 of the VDR, in which site-specific methylation
distinguished ethnicity and TB status [88]. In South African Black children, the minor “T” (f) allele of
FokI correlated with susceptibility to respiratory syncytial virus infection [89], as similarly reported in
Dutch children [91]. A recent study of Black African and Coloured adults in Cape Town found FokI
“AG” associated with lower serum 25(OH)D levels, as well as a lower 25(OH)D status in winter and
following supplementation with vitamin D [38]. The impact of FokI on VDR function was examined
using monocytes from healthy South African Blacks and Whites [90]. Despite having higher levels of
more active VDR, monocytes from Blacks showed reduced transactivation of the gene encoding the
cathelicidin antimicrobial protein (CAMP), compared to Whites, unless supplemented in vitro with
1,25(OH)2D3. Thus the association of VDR polymorphisms with disease in the population groups of
South Africa appears to be ethnicity-dependent, involving complex interactions between genetics,
epigenetics and the environment.
7. Conclusions
A systematic search of the published literature provided limited but important information
relating to the vitamin D status of the South African population. The study protocols were varied,
involving males and females of different ages, ethnicities, skin colours and places of residence, together
with a range of methods to measure 25(OH)D levels. Despite these considerable shortcomings,
25(OH)D levels were generally found to be sufficient (>50 nmol/L) in most healthy people, although
they were frequently insufficient in Asian/Indians and in the elderly (>65 years) and it should be noted
that little data are available for those living at the higher southern latitudes of the country, especially
during the winter months. The few studies investigating whether urbanisation might lead to an
increase or decrease in vitamin D status have yielded contradictory results. A combination of factors is
involved here: for example, less exposure to the sun might be predicted in urban compared with rural
environments with a consequent reduction in 25(OH)D levels, but on the other hand, urbanisation
might lead to a higher standard of living with the consumption of more foods containing vitamin D and
its metabolites. A low dietary intake of vitamin D occurs throughout South Africa, emphasising the
importance of exposure to the sun in determining vitamin D status. The use of vitamin D supplements
amongst South Africans is not common.
Reports investigating vitamin D status in relation to disease, have yielded inconsistent results,
with half finding a relationship between 25(OH)D deficiency and disease or its severity, and half
finding no such association. The majority of the studies falling into the latter category were in the
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North of the country where the mean 25(OH)D levels tended to be higher compared with the South
(Figure 1, Table 3). Most studies were cross-sectional or case-control so that establishing the temporal
relationships and thus revealing whether low 25(OH)D levels are a cause, consequence or proxy for a
“true” risk factor is not possible. Similarly, the sample sizes tended to be small, especially in the earlier
reports, and were underpowered to detect an effect on disease risk. Furthermore the population groups
and ages varied, and the disorders covered a very wide range, with bone pathologies and IDs being
most common. It is of interest that 1,25(OH)2D interacts with cells of the immune system including
monocytes/macrophages, dendritic cells, B and T cells, leading to modulation of many inflammatory
responses through various signalling pathways [91]. Inflammation and infection can associate with low
25(OH)D levels, and linkage studies may identify consequence rather than cause. Whether vitamin D
deficiency is causal to disease or not, the significant burden of deficiency in individuals with a variety
of disorders in South Africa suggests that vitamin D supplements should be part of the therapy, at least
to maintain bone health but also possibly to enhance recovery and disease resolution. In addition
it is becoming clear that not all the immunomodulatory effects of exposure to solar UVR are due
to vitamin D [92]. Further work in this area is merited, particularly concentrating on the disorders
that present major health burdens in South Africa currently, such as HIV, TB, cardiovascular diseases,
T2DM and various cancers.
It is not possible at the present time to give accurate advice to the general public, based on scientific
findings, regarding how much sun exposure is optimal for health. There are many environmental
variables to take into consideration, such as the latitude of residence, season, time of day, cloud
cover and surface reflectivity. In addition variations in personal factors, including skin pigmentation
and the extent of clothing, require that the health messages are adapted to make them relevant for
each ethnic group. Given the climate of South Africa, there should be ample opportunity to attain
vitamin D sufficiency throughout the year for those living in the northern Provinces and in all but
the winter months for those living in the southern Provinces when there is limited UVB in sunlight.
Our review shows that some populations are at increased risk of vitamin D deficiency. These include
the elderly, those in residential care, Asian-Indian women who tend to be fully clothed, those with
deeply pigmented skin, and people infected with HIV and M. tuberculosis. It is possible that the obese
and workers employed underground or on night shifts may also be at risk of deficiency. All, or at least
some, of these groups may benefit from vitamin D supplementation.
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